<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kuznar, Wayne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Boehmer, John P.</style></author><author><style face="normal" font="default" size="100%">Grace, Andrew</style></author><author><style face="normal" font="default" size="100%">Neuzil, Petr</style></author><author><style face="normal" font="default" size="100%">Ritter, Philippe</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">New Implantable Technologies Improve Prognosis of Patients With CHF</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-07-02 10:57:42</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">24-25</style></pages><abstract><style  face="normal" font="default" size="100%">In advanced heart failure, patient prognosis is being influenced by new technologies in cardiovascular implantable electronic devices, including a totally subcutaneous implantable cardioverter defibrillator with an impressive complication-free rate, leadless cardiac pacing, and multiple-sensor ICDs that are better able to monitor heart failure status.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>